Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Human immunodeficiency virus (HIV) reverse transcriptase (RT)-associated ribonuclease H (RNase H) remains the only virally encoded enzymatic function yet to be exploited as an antiviral target. One of the possible challenges may be that targeting HIV RNase H is confronted with a steep substrate barrier. We have previously reported a 3-hydroxypyrimidine-2,4-dione (HPD) subtype that potently and selectively inhibited RNase H without inhibiting HIV in cell culture. We report herein a critical redesign of the HPD chemotype featuring an additional wing at the C5 position that led to drastically improved RNase H inhibition and significant antiviral activity. Structure-activity relationship (SAR) concerning primarily the length and flexibility of the two wings revealed important structural features that dictate the potency and selectivity of RNase H inhibition as well as the observed antiviral activity. Our current medicinal chemistry data also revealed that the RNase H biochemical inhibition largely correlated the antiviral activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Retroviral integrase superfamily: the structural perspective
Nowotny, M. (2009) · The EMBO Reports · doi:10.1038/embor.2008.256 · Cited by 183
HIV-1 ribonuclease H: structure, catalytic mechanism and inhibitors
Beilhartz, G. L., & Götte, M. (2010) · Viruses · doi:10.3390/v2040900 · Cited by 88 · cited 1×
“13 Chemotypes known for active site RNase H inhibition include 2-hydroxyisoquinolinedione (HID, 1),14-16 β-thujaplicinol (2),17 dihydroxycoumarin (3),18 diketoacid (4),19 pyrimidinol carboxylic acid (5),20 hydroxynaphthyridine (6)21 and pyridopyrimidone 7.”
BackgroundDas, K., Martinez, S. E., Bandwar, R. P., & Arnold, E. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku487 · Cited by 68
Kankanala, J., Kirby, K. A., Liu, F., Miller, L., Nagy, E., Wilson, D. J., Parniak, M. A., Sarafianos, S. G., & Wang, Z. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00465 · Cited by 66
Self-citationActive site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase
Corona, A., Masaoka, T., Tocco, G., Tramontano, E., & Le Grice, S. F. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.178 · Cited by 54
Research works printed but not linked: 33
- 10.1016/j.jhep.2005.11.021 · DOI
- 10.1146/annurev-med-011514-023043 · DOI · Paper page
- 10.1016/j.coi.2016.05.015 · DOI
- 10.1016/j.jmb.2008.10.071 · DOI · Paper page
- 10.1016/j.antiviral.2009.09.014 · DOI · Paper page
- 10.3390/v2020606 · DOI
- 10.1016/j.antiviral.2009.09.008 · DOI · Paper page
- 10.1093/nar/gkg881 · DOI · Paper page
- 10.1021/jm1014692 · DOI · Paper page
- 10.1021/ml400009t · DOI
- 10.1016/j.str.2009.09.016 · DOI · Paper page
- 10.1016/j.jmb.2014.05.006 · DOI · Paper page
- 10.1074/jbc.C200621200 · DOI · Paper page
- 10.1128/AAC.01594-10 · DOI · Paper page
- 10.1016/j.bmcl.2010.08.135 · DOI
- 10.1074/jbc.M114.569707 · DOI · Paper page
- 10.1021/acs.jmedchem.6b00040 · DOI
- 10.1021/acs.jmedchem.5b01879 · DOI
- 10.1021/jm501132s · DOI · Paper page
- 10.1021/acs.jmedchem.6b00040 · DOI
- 10.1016/j.ejmech.2017.01.041 · DOI
- 10.1021/ml1002162 · DOI
- 10.1021/jm1014378 · DOI
- 10.1021/jm501132s · DOI · Paper page
- 10.1021/jm401232v · DOI
- 10.1021/cb600303y · DOI · Paper page
- 10.1021/jm800245z · DOI · Paper page
- 10.1021/jm400645w · DOI · Paper page
- 10.1006/prep.1996.0004 · DOI
- 10.1016/j.ab.2003.06.001 · DOI
- 10.1021/jm070512p · DOI · Paper page
- 10.1021/jm401232v · DOI
- 10.1128/JVI.79.18.11952-11961.2005 · DOI · Paper page
Cited by
Avoiding drug resistance in HIV reverse transcriptase
Cilento, M. E., Kirby, K. A., & Sarafianos, S. G. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00967 · Cited by 106
Self-citationWang, L., Sarafianos, S. G., & Wang, Z. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00450 · Cited by 43
Self-citationWang, L., Tang, J., Huber, A. D., Casey, M. C., Kirby, K. A., Wilson, D. J., Kankanala, J., Xie, J., Parniak, M. A., Sarafianos, S. G., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.07.039 · Cited by 36
Self-citationDesantis, J., Massari, S., Corona, A., Astolfi, A., Sabatini, S., Manfroni, G., Palazzotti, D., Cecchetti, V., Pannecouque, C., Tramontano, E., et al. (2020) · Molecules · doi:10.3390/molecules25051183 · Cited by 29
Retroviral RNase H: structure, mechanism, and inhibition
(2021) · The Enzymes · doi:10.1016/bs.enz.2021.07.007 · Cited by 13
Metadata
- Authors
- Vernekar, S. K. V., Tang, J., Wu, B., Huber, A. D., Casey, M. C., Myshakina, N., Wilson, D. J., Kankanala, J., Kirby, K. A., Parniak, M. A., Sarafianos, S. G., & Wang, Z.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-05-31
- Volume
- 60
- Issue
- 12
- Pages
- 5045-5056
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2615815774
- Cited by
- 41
- References
- 5
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- National Institute of Allergy and Infectious Diseases (AI100890)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity. https://app.cochat.ai/papers/10.1021/acs.jmedchem.7b00440
- The paper
- Vernekar, S. K. V., Tang, J., Wu, B., Huber, A. D., Casey, M. C., Myshakina, N., Wilson, D. J., Kankanala, J., Kirby, K. A., Parniak, M. A., Sarafianos, S. G., & Wang, Z. (2017). Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.7b00440
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.